pancreaticObserve forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.Binds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.antidiabetic,long-actinginsulinBasaglar,Lantus,ToujouAntidiabetics,rapid actinginsulinsShake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Inform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.Novologchest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.AlbuterolSulfate InsulinGlargineAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Instruct ptsto contactHCPimmediatelyof SOB.SCExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Do not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.Do not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.Instruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.Assess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Stimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.PO/inhalationhypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.Administersubq within 5-10min beforemeal. Rotateinjection sites.onset iswithin15minMonitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.InsulinApartTreatment&prevention ofbronchospasmin asthma andCOPD.onset iswithin 3to 4hrMonitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumCaution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.controlhyperglycemiain pts withT1/T2 DM.Administer oralmed with mealsto minimizegastric irritationBronchodilators;adrenergicpancreaticObserve forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.Binds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.antidiabetic,long-actinginsulinBasaglar,Lantus,ToujouAntidiabetics,rapid actinginsulinsShake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.Explain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Inform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.Novologchest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.AlbuterolSulfate InsulinGlargineAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Instruct ptsto contactHCPimmediatelyof SOB.SCExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Do not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.Do not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.Instruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.Assess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Stimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.PO/inhalationhypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.Administersubq within 5-10min beforemeal. Rotateinjection sites.onset iswithin15minMonitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.InsulinApartTreatment&prevention ofbronchospasmin asthma andCOPD.onset iswithin 3to 4hrMonitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumCaution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.controlhyperglycemiain pts withT1/T2 DM.Administer oralmed with mealsto minimizegastric irritationBronchodilators;adrenergic

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. pancreatic
  2. Observe for paradoxical bronchospasm (wheezing). Notify HCP immediately if condition occurs.
  3. Binds to beta 2 adrenergic receptors in airway smooth muscle by inhibiting phosphorylation of myosin and decrease intracellular calcium leads to relaxation of smooth muscle airways.
  4. antidiabetic, long-acting insulin
  5. Basaglar, Lantus, Toujou
  6. Antidiabetics, rapid acting insulins
  7. Shake inhaler well and allow at least 1min btw inhalations. Prime inhaler before first use by releasing 4 test sprays.
  8. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  9. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  10. Inform pts of unusual bad taste. Advise pts to rinse mouth after each inhalation to minimize dry mouth.
  11. Novolog
  12. chest pain, palpitations, nervousness, restlessness, tremor, paradoxical bronchospasm w/excessive use.
  13. Albuterol Sulfate
  14. Insulin Glargine
  15. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  16. Instruct pts to contact HCP immediately of SOB.
  17. SC
  18. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  19. Do not mix insulin Glargine with other insulin. If giving with a short acting insulin, use separate syringes and diff injection sites.
  20. Do not draw up dose into a syringe from the kiwi pens, syringe markings do not match up and could lead to medication error. Prior to withdrawing dose, rotate vial btw palms to ensure uniform solution; do not shae.
  21. Instruct pts on proper techniques for admin. Demonstrate technique for mixing insulins by drawing up insulin Aspart first.
  22. Assess lung sounds, pulse, BP before admin and during peak of med. Note amount, color, and character of sputum produced.
  23. Stimulate glucose uptake in skeletal muscle and fat, inhibit hepatic glucose production.
  24. PO/inhalation
  25. hypoglycemia, hypokalemia, erythema, lipodystrophy, pruritus, swelling.
  26. Administer subq within 5-10min before meal. Rotate injection sites.
  27. onset is within 15min
  28. Monitor pulmonary function test before initiating therapy and periodically during therapy.
  29. Insulin Apart
  30. Treatment &prevention of bronchospasm in asthma and COPD.
  31. onset is within 3 to 4hr
  32. Monitor for hypokalemia as albuterol may cause a decrease in serum potassium
  33. Caution pt not to exceed recommended dose, may cause adverse effects or loss of effectiveness of med.
  34. control hyperglycemia in pts with T1/T2 DM.
  35. Administer oral med with meals to minimize gastric irritation
  36. Bronchodilators; adrenergic